Amanote Research
Register
Sign In
Use of Short-Acting Insulin Aspart in Managing Older People With Diabetes
Clinical Interventions in Aging
- New Zealand
doi 10.2147/cia.s3142
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Gerontology
Geriatrics
Date
April 1, 2009
Authors
Alan Sinclair
Publisher
Informa UK Limited
Related search
Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes
Prescriber
Pharmacology
Faster-Acting Insulin Aspart Provides Faster Onset and Greater Early Exposure vs Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Pediatric Diabetes
Internal Medicine
Pediatrics
Endocrinology
Perinatology
Child Health
Metabolism
Diabetes
A Survey of Physician Experience and Treatment Satisfaction Using Fast-Acting Insulin Aspart in People With Type 1 or Type 2 Diabetes
Postgraduate Medicine
Medicine
The Association Between Anti‐insulin Aspart Antibodies and the Pharmacokinetic and Pharmacodynamic Characteristics of Fast‐acting Insulin Aspart in Children and Adolescents With Type 1 Diabetes
Pediatric Diabetes
Internal Medicine
Pediatrics
Endocrinology
Perinatology
Child Health
Metabolism
Diabetes
Safety, Immunogenicity and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People With Diabetes Also Using Insulin Glargine: 12-Month Results From the GEMELLI 1 Trial
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Efficacy and Safety of Fast-Acting Insulin Aspart in People With Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations
Turkish Journal of Endocrinology and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D
Pharmacology
